NI
CELG

Nepsis Inc’s Celgene Corp CELG Stock Holding History

Nepsis Inc’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-85,546
Closed -$5.51M – 37
2018
Q4 		$5.51M Buy
+85,546
New +$6.31M 3.65% 12
2016
Q2 		– Sell
-34,969
Closed -$3.5M – 43
2016
Q1 		$3.5M Sell
34,969
-6,254
-15% -$644K 1.88% 29
2015
Q4 		$4.94M Sell
41,223
-1,083
-3% -$125K 2.86% 18
2015
Q3 		$4.58M Sell
42,306
-2,401
-5% -$298K 2.72% 20
2015
Q2 		$5.34M Buy
44,707
+3,609
+9% +$413K 3.6% 16
2015
Q1 		$4.74M Sell
41,098
-7,998
-16% -$956K 2.86% 17
2014
Q4 		$5.49M Sell
49,096
-11,059
-18% -$1.17M 3.2% 15
2014
Q3 		$4.25M Sell
60,155
-6,573
-10% -$593K 2.43% 10
2014
Q2 		$5.91M Sell
66,728
-3,796
-5% -$289K 3.25% 10
2014
Q1 		$5.17M Buy
70,524
+21,648
+44% +$1.71M 3.14% 10
2013
Q4 		$4.13M Buy
+48,876
New +$3.87M 2.85% 18

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nepsis Inc's CELG Position: Q1 2019 in Review

Nepsis Inc sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 85,546 shares — an estimated $5.51M sold.

Nepsis Inc first reported a position in CELG in Q4 2013 and held it in 11 quarters. The position peaked at $5.91M in Q2 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Nepsis Inc reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Nepsis Inc sold 85,546 Celgene Corp shares in Q1 2019, an estimated $5.51M.
  • Nepsis Inc first reported a position in Celgene Corp in Q4 2013 and held it in 11 quarters.
  • Nepsis Inc's Celgene Corp position peaked at $5.91M in Q2 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Nepsis Inc's 13F filing for Q1 2019, filed 26 Apr 2019.